Suchergebnisse - "Takashima, Atsuo"

PubPharm (342)

1

Multi-institutional observational study evaluating the efficacy of anti-epidermal growth factor antibody re- challenge in RAS/BRAF wild-type metastatic colorectal cancer

enthalten in: ResearchSquare.com | 2024

von Fukuda, K. | Osumi, H. | Yoshinami, Y. | +17

2

Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A)

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2024

von Kataoka, K. | Ouchi, A. | Suwa, Y. | +18

3

Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer : a prospective, single center, observational study

enthalten in: International journal of clinical oncology | 2024

von Katsuya, Y. | Yoshida, T. | Takashima, A. | +10

4

Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin

enthalten in: In vivo (Athens, Greece) | 2024

von Yada, M. | Yamamoto, S. | Honma, Y. | +7

5

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

enthalten in: Nature medicine | 2024

von Shitara, K. | Muro, K. | Watanabe, J. | +28

6

Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma

enthalten in: Esophagus : official journal of the Japan Esophageal Society | 2024

von Hirose, T. | Yamamoto, S. | Honma, Y. | +11

7

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer : Results of the Japanese Expanded Access Program

enthalten in: Clinical colorectal cancer | 2024

von Kotani, D. | Takashima, A. | Kato, T. | +16

8

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study) : an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

9

Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study

enthalten in: International journal of clinical oncology | 2024

von Katsuya, Y. | Yoshida, T. | Takashima, A. | +10

10

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric Cancer | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[35]